Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 5,222 shares at $27.30 ($143K) on 2026-06-08, disclosed to the SEC on 2026-06-09.
Open-market sale of $143k URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-05-11 | $300K | — | Filing → |